Rating Change
B of A Securities analysts initiated coverage on AxoGen, Inc. (NASDAQ:AXGN) with a rating of Buy on October 12, 2026.
new coverageNASDAQ:AXGN
B of A Securities Initiates Coverage on AxoGen, Inc. (AXGN) with Buy
B of A Securities analysts initiated coverage on AxoGen, Inc. (NASDAQ:AXGN) with a rating of Buy on October 12, 2026.
At publication ·
What changed
AxoGen, Inc. (NASDAQ:AXGN) · new coverage
- Firm
- B of A Securities
- Rating
- Buy
- Price at event
- $37.11
- Market capitalization
- $1.4B
At a glance
Key takeaways
- B of A Securities initiated Buy coverage on AxoGen (AXGN) on October 12, 2026, with the stock trading at $37.11 and a market cap of $1.4 billion.
Market Context
AxoGen, Inc. operates in the Healthcare sector. The stock currently trades at $37.11 with a market capitalization of $1.4B.
Analyst coverage from B of A Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for AxoGen, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for AxoGen, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 12, 2026 | B of A Securities | Buy | N/A |
| Oct 07, 2026 | Barclays | Overweight | N/A |
| Oct 01, 2026 | Truist Securities | Buy | N/A |
| Sep 25, 2026 | Raymond James | Outperform | N/A |
| Aug 26, 2026 | Truist Securities | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View AXGN Stock Page
Frequently Asked Questions
What does the Buy rating mean for AXGN?
A rating of Buy from B of A Securities reflects the analyst's outlook on AxoGen, Inc. (NASDAQ:AXGN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the AXGN forecast page.
